Our goal is to create a large tumor registry by collecting data on disease characterization, treatment, tumor molecular profiles, and outcomes for patients with ovarian granulosa cell tumors (GCT). This registry will help support research to answer important questions about environmental risk factors, genetic causes, and the effectiveness of treatment approaches.

No. The registry is open to eligible patients who have been treated by any medical facility.

Yes. Please contact the registry for more information.

No. There is no cost or compensation associated with participation in the registry.

Participants can withdraw from the registry study at any point.